Biofrontera Balance Sheet Health
Financial Health criteria checks 5/6
Biofrontera has a total shareholder equity of €16.2M and total debt of €2.2M, which brings its debt-to-equity ratio to 13.3%. Its total assets and total liabilities are €29.0M and €12.9M respectively. Biofrontera's EBIT is €1.4M making its interest coverage ratio 1. It has cash and short-term investments of €1.2M.
Key information
13.3%
Debt to equity ratio
€2.16m
Debt
Interest coverage ratio | 1x |
Cash | €1.18m |
Equity | €16.19m |
Total liabilities | €12.85m |
Total assets | €29.04m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: B8FE's short term assets (€11.8M) exceed its short term liabilities (€11.4M).
Long Term Liabilities: B8FE's short term assets (€11.8M) exceed its long term liabilities (€1.5M).
Debt to Equity History and Analysis
Debt Level: B8FE's net debt to equity ratio (6.1%) is considered satisfactory.
Reducing Debt: B8FE's debt to equity ratio has reduced from 258.4% to 13.3% over the past 5 years.
Debt Coverage: B8FE's debt is well covered by operating cash flow (1548.7%).
Interest Coverage: B8FE's interest payments on its debt are not well covered by EBIT (1x coverage).